格隆汇1月5日丨合富中国(603122.SH)公布，公司于2026年1月5日收到合富香港出具的《关于提前终止 减持计划暨减持结果的告知函》，合富香港自2025年12月24日至2025年12月31日期间内，通过集中竞价 方式减持公司股份398万股，占公司总股本的0.9999%，以上减持已达到合富香港资金需求，合富香港 决定提前终止本次减持计划，以表达对公司未来发展的信心及支持。 ...

证券代码：603122 证券简称：合富中国 公告编号：2026-001 合富（中国）医疗科技股份有限公司 控股股东提前终止减持计划暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上述减持主体无一致行动人。 二、减持计划的实施结果 (一)大股东因以下事项披露减持计划实施结果： 控股股东持股的基本情况 本次减持计划实施前，合富（中国）医疗科技股份有限公司（以下简称"公 司"）控股股东合富（香港）控股有限公司（以下简称"合富香港"）持有公司股 票 218,937,885 股，占公司总股本的 55.0022%，上述股份全部来源于公司 IPO 前取得，均为无限售流通股。 公司于 2025 年 12 月 3 日披露了《合富（中国）医疗科技股份有限公司控股 股东减持股份计划公告》（公告编号：2025-065），合富香港计划通过大宗交易方 式和集中竞价交易方式减持公司股份数量合计不超过 7,961,052 股（合计不超过 公司总股本的 2%），其中通过大宗交易方式减持公司股份数量不超过 3,980 ...

合富中国公告，公司控股股东合富香港原计划自2025年12月24日至2026年3月23日减持不超796.11万 股，占2%，其中集中竞价398.05万股、大宗交易398.05万股；截至2025年12月31日已通过集中竞价减持 398万股，占0.9999%，价格区间24.21～26.44元/股，套现9919.37万元；因资金需求已满足，决定提前 终止减持计划，减持后持股2.15亿股，占54.0024%。 ...

格隆汇1月5日丨合富中国(603122.SH)在投资者互动平台表示,目前公司业务重心聚焦于大中华市场,服务 客户主要为大陆及中国台湾的医疗机构,并将自身定位为"医院高质量发展伙伴",公司的业务范围暂不涉 及欧盟国家。公司管理团队始终密切关注行业发展趋势,积极寻求新项目合作、投资等合作扩能机会,助 力业务区域覆盖,以期实现长期可持续成长,为广大投资者创造长期投资价值。 ...

Market Performance - The pharmaceutical commercial sector increased by 1.77% compared to the previous trading day, with Jia Shitang leading the gains [1] - The Shanghai Composite Index closed at 4023.42, up 1.38%, while the Shenzhen Component Index closed at 13828.63, up 2.24% [1] Individual Stock Performance - Jia Shitang (002462) closed at 15.80, up 10.03% with a trading volume of 224,800 shares [1] - Saily Medical (603716) closed at 22.61, up 10.02% with a trading volume of 133,500 shares [1] - Baiyang Pharmaceutical (301015) closed at 25.23, up 6.91% with a trading volume of 83,200 shares [1] - Other notable performers include Dajia Weikang (301126) up 6.51%, and Run Da Medical (603108) up 5.82% [1] Capital Flow Analysis - The pharmaceutical commercial sector saw a net inflow of 231 million yuan from institutional investors, while retail investors contributed a net inflow of 71.88 million yuan [2] - However, there was a net outflow of 303 million yuan from speculative funds [2] Detailed Capital Flow for Key Stocks - Saily Medical (603716) had a net inflow of 1.59 billion yuan from institutional investors, but a net outflow of 71.84 million yuan from speculative funds [3] - Jia Shitang (002462) experienced a net inflow of 86.98 million yuan from institutional investors, with a net outflow of 45.96 million yuan from speculative funds [3] - Hua Ren Health (301408) had a net inflow of 45.75 million yuan from institutional investors, but a significant net outflow of 65.32 million yuan from retail investors [3]

Market Overview - The Shanghai Composite Index rose by 0.09% on December 31, with 15 industries experiencing gains, led by defense and military industry at 2.13% and media at 1.54% [1] - The communication and agriculture, forestry, animal husbandry, and fishery sectors saw the largest declines, down 1.35% and 1.10% respectively [1] - The pharmaceutical and biotechnology sector fell by 0.45% [1] Capital Flow Analysis - The main capital outflow from the two markets totaled 32.27 billion yuan, with 9 industries seeing net inflows [1] - The defense and military industry had the highest net inflow of 6.06 billion yuan, followed by the media sector with 4.45 billion yuan [1] - A total of 22 industries experienced net capital outflows, with the electronics sector leading at 11.20 billion yuan, followed by the power equipment sector at 7.25 billion yuan [1] Pharmaceutical and Biotechnology Sector - The pharmaceutical and biotechnology sector saw a net outflow of 3.54 billion yuan, with 178 of the 478 stocks in the sector rising and 276 falling, including one stock hitting the daily limit down [2] - The top three stocks with net inflows in this sector were Meinian Health (84.95 million yuan), Huaren Health (75.69 million yuan), and Xingqi Eye Medicine (64.86 million yuan) [2] - The stocks with the largest net outflows included WuXi AppTec (468.14 million yuan), Mindray Medical (321.35 million yuan), and Hefei China (276.65 million yuan) [3]

Market Performance - On December 31, major indices showed volatility, with the Shanghai Composite Index slightly up by 0.09%, while the Shenzhen Component Index fell by 0.58%, the ChiNext Index dropped by 1.23%, and the STAR Market 50 Index decreased by 1.15% [2] - Over 2,300 stocks in the two markets were in the green, with a total trading volume reaching approximately 2.05 trillion yuan [2] AI and Technology Sector - AI application concept stocks led the gains, with BlueFocus (300058.SZ) rising by 20%, iReader Technology (603533.SH) increasing by 10%, and Century Tianhong (300654.SZ) and Chinese Online (300364.SZ) experiencing significant increases [2] - Meta announced the acquisition of the general AI agent platform Manus, marking its third-largest acquisition to date. Manus has processed over 147 trillion tokens and created 80 million virtual computers, serving millions of users [2] Aerospace Sector - The commercial aerospace concept remained active, with Aerospace Universe (688523.SH) rising over 14%, and China Satellite (600118.SH) and Aerospace Development (000547.SZ) both increasing by 10% [2] - On December 31, China successfully launched the Practice-29 satellite using the Long March 7 modified carrier rocket, marking the 623rd flight of the Long March series and a record 73 space launch missions completed in 2025 [3] Aviation and Education Sector - The airport and shipping sector strengthened, with companies like Juneyao Airlines (603885.SH) up by 7.2%, and China Eastern Airlines (600115.SH), China Southern Airlines (600029.SH), and Air China (601111.SH) also seeing gains [4] - The upcoming New Year holiday is expected to drive a surge in passenger traffic, with the Civil Aviation Administration predicting a 4.9% year-on-year increase in passenger throughput from January 1 to 3, 2026 [4] - The education sector also performed well, with Kevin Education (002659.SZ) hitting the daily limit up by 10%, and other companies like Zhonggong Education (002607.SZ) and Dou Shen Education (300010.SZ) showing significant increases [4] - The Ministry of Education plans to advance AI in education, with policies expected to be released next year to promote AI knowledge education and develop a future-oriented education system [4] Declining Sectors - The liquor and pharmaceutical commercial sectors weakened, with companies like Hefei China (603122.SH), Kweichow Moutai (600519.SH), and Gujing Gongjiu (000596.SZ) experiencing declines [5] - The chip and lithium battery sectors also faced downturns, with Saiwei Electronics (300456.SZ) dropping by 9.96%, and other companies like Cambrian (688256.SH), EVE Energy (300014.SZ), and CATL (300750.SZ) also declining [5]

Core Viewpoint - The A-share market may experience a 30% increase in the index by 2025, but individual accounts may remain flat due to concentrated investments in specific hot stocks each month rather than broad market gains [1]. Monthly Performance Summary - January: The robot sector surged, turning an initial investment of 10,000 into 18,400 due to the popularity of humanoid robots [3]. - February: The DeepSeek model led to a valuation increase in computing power, with returns reaching 46,200 from 10,000, marking a 150.97% increase [6]. - March: Chemical products saw price increases, with an investment growing to 158,200, reflecting a 135.41% rise [6]. - April: The new retail concept gained traction amid tariff disputes, with a notable stock rising by 117.1% [6]. - May: The military and pharmaceutical sectors alternated in popularity, with AI logistics becoming a new focus, resulting in a 157.28% increase [6]. - June: Military equipment stocks surged due to geopolitical tensions, with returns reaching 159.97% [6]. - July: The rumor of Zhiyuan's acquisition led to a dramatic rise in the humanoid robot sector, with a staggering 1,083.42% increase [6]. - August: AI chip companies reported improved earnings, and battery prices stabilized, leading to a 110.36% increase [6]. - September: The release of energy storage policies accelerated market growth, with returns of 153.52% [6]. - October: Regional policies boosted stocks, with a 99.44% increase [6]. - November: The focus shifted to defensive stocks amid market adjustments, with a 143.31% increase [6]. - December: The commercial aerospace sector concluded the year strongly, with a 104.83% increase [6]. Overall Investment Growth - An initial investment of 10,000 grew to 993 million over the year through strategic monthly trading [4].

SPD概念板块领跌，下跌1.02%，其中合富中国下跌5.04%，英特集团下跌2.8%，塞力医疗下跌1.15%。 （AI生成） ...

Market Overview - The pharmaceutical commercial sector experienced a slight decline of 0.0% on December 30, with Saily Medical leading the drop [1] - The Shanghai Composite Index closed at 3965.12, also down by 0.0%, while the Shenzhen Component Index rose by 0.49% to 13604.07 [1] Stock Performance - Notable gainers in the pharmaceutical sector included: - Yingte Group (000411) with a closing price of 13.23, up by 9.98% and a trading volume of 419,800 shares [1] - Yao Yigou (300937) at 35.65, up by 7.64% with 125,700 shares traded [1] - HeFu China (603122) at 26.00, up by 6.17% with a trading volume of 985,200 shares [1] - Conversely, Saily Medical (603716) saw a decline of 3.19% to a closing price of 20.95, with a trading volume of 123,200 shares [2] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 258 million yuan from institutional investors, while retail investors contributed a net inflow of 54.61 million yuan [2] - Notable capital flows included: - HeFu China (603122) with a net inflow of 286 million yuan from institutional investors [3] - Yingte Group (000411) with a net inflow of 134 million yuan from institutional investors [3] - Yao Yigou (300937) with a net inflow of 16.36 million yuan from institutional investors [3]